Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.

There’s no need to rush into doing anything with the Lisa. There is always a possibility that future rule changes could allow ...

Mar 19, 2026 // A new white paper from Accountability Lab’s Florencia Guerzovich, PhD, delves deeply into how the Democracy, ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the fourth quarter and full year of 2025. In 2024, the ...

Objective To evaluate the safety and durability of telitacicept treatment in patients with SLE by identifying the reasons for ...